Drug Trial Radar · NCT06931340
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,260
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Nov 11, 2031
Study completion May 8, 2039
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Apr 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Hormone therapy for prostate cancer, also called androgen deprivation therapy (ADT), uses surgery or drugs to lower the levels of male sex hormones in a man's body. This helps slow the growth of prostate cancer. Apalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of tumor cells. Giving docetaxel in addition to the usual treatment of hormonal therapy and apalutamide may work better in treating patients with metastatic prostate cancer than the usual treatment alone.
Conditions
- Castration-Sensitive Prostate Carcinoma
- Metastatic Prostate Adenocarcinoma
- Stage IVB Prostate Cancer AJCC v8
Interventions
Androgen TherapyDrug
Given ADT
ApalutamideDrug
Given PO
DocetaxelDrug
Given IV
Computed TomographyProcedure
Undergo CT
Magnetic Resonance ImagingProcedure
Undergo MRI
Bone ScanProcedure
Undergo Bone Scan
PSMA PET ScanProcedure
Undergo PSMA PET Scan
Biospecimen CollectionProcedure
Undergo blood sample collection
Questionnaire AdministrationOther
undergo Questionnaire Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival (OS)Time frame: From randomization to death due to any cause, assessed up to 10 years
Locations
214 sites in 1 country. Site status is shown where the registry gives one.
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
University of Arizona Cancer Center-North Campus
Tucson, Arizona · Recruiting
Kaiser Permanente Dublin
Dublin, California · Recruiting
Kaiser Permanente-Fremont
Fremont, California · Recruiting
Kaiser Permanente Fresno Orchard Plaza
Fresno, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
Kaiser Permanente- Modesto MOB II
Modesto, California · Recruiting
Kaiser Permanente-Modesto
Modesto, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Eisenhower Medical Center
Rancho Mirage, California · Recruiting
Kaiser Permanente-Roseville
Roseville, California · Recruiting
Kaiser Permanente Downtown Commons
Sacramento, California · Recruiting
Kaiser Permanente-South Sacramento
Sacramento, California · Recruiting
UC San Diego Medical Center - Hillcrest
San Diego, California · Recruiting
Kaiser Permanente-San Francisco
San Francisco, California · Recruiting
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California · Recruiting
Kaiser Permanente San Leandro
San Leandro, California · Recruiting
Kaiser San Rafael-Gallinas
San Rafael, California · Recruiting
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California · Recruiting
Kaiser Permanente-Santa Rosa
Santa Rosa, California · Recruiting
Kaiser Permanente-South San Francisco
South San Francisco, California · Recruiting
Kaiser Permanente-Vallejo
Vallejo, California · Recruiting
Kaiser Permanente-Walnut Creek
Walnut Creek, California · Recruiting
Rocky Mountain Regional VA Medical Center
Aurora, Colorado · Recruiting
Kaiser Permanente-Franklin
Denver, Colorado · Recruiting
Shaw Cancer Center
Edwards, Colorado · Recruiting
Saint Mary's Hospital and Regional Medical Center
Grand Junction, Colorado · Recruiting
Kaiser Permanente-Rock Creek
Lafayette, Colorado · Recruiting
Kaiser Permanente-Lone Tree
Lone Tree, Colorado · Recruiting
Bayhealth Hospital Kent Campus
Dover, Delaware · Active not recruiting
Bayhealth Hospital Sussex Campus
Milford, Delaware · Active not recruiting
MedStar Georgetown University Hospital
Washington D.C., District of Columbia · Recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Recruiting
Malcom Randall Veterans Administration Medical Center
Gainesville, Florida · Recruiting
Northside Hospital
Atlanta, Georgia · Recruiting
Northside Hospital - Duluth
Duluth, Georgia · Recruiting
Northside Hospital - Gwinnett
Lawrenceville, Georgia · Recruiting
Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii · Recruiting
Saint Luke's Cancer Institute - Boise
Boise, Idaho · Recruiting
Kootenai Health - Coeur d'Alene
Coeur d'Alene, Idaho · Recruiting
Showing 40 of 214 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.